Arunesh Verma
Arunesh is President of Fresenius Kabi in the United States and a member of the company’s global Executive Leadership Team. Fresenius Kabi is a leading U.S. developer and manufacturer of injectable medicines and biosimilars. Arun has deep experience in essential medicines with past roles of increasing responsibility at Cipla where he was CEO of North America, […]
Maryll Toufanian
Maryll Toufanian is Senior Vice President, Regulatory Strategy and Government Affairs, at Amneal Pharmaceuticals Inc., where she leads the company’s efforts to develop top-level regulatory strategies. She also leads Amneal’s government relations and public policy interface with state and federal policymakers. Prior to Amneal, Maryll held senior leadership roles at the FDA and served as […]
Veerappan Subramanian Ph.D.
Veerappan Subramanian Ph.D. is the Chief Executive Officer of Somerset Therapeutics LLC. Veerappan is a veteran in the industry with over 50 years in the pharmaceutical business including Squibb, Johnson & Johnson, and Richardson-Merrell. After retiring from IVAX/Zenith as the Chief Scientific Officer in 1996, he has owned and operated three generic pharmaceutical companies. He is […]
Brandon Rockwell
Brandon Rockwell is Chief Operating Officer at PAI Pharma where he is responsible for PAI’s Growth Strategy. At PAI, he has responsibility for various functions in the organization including R&D, Regulatory, Business Development, Project / Alliance Management and Operations. Brandon has over 15 years of Pharma experience and has held various areas of responsibilities in […]
Punit Patel
Punit Patel is the President and Chief Executive Officer, Americas, Zydus Group. He is responsible for the business operations of all Zydus entities in North America which include generics, injectables and specialty business, rare and orphan disease portfolio and also future forays into novel therapeutics. Punit has more than 20 years of experience in the generics […]
Paul McMahon
Paul McMahon is President, Commercial Operations, at Aurobindo Pharma USA, Inc. He joined Aurobindo in 2009 as Director, National Accounts and has held roles with increased responsibility during his tenure. Prior to joining Aurobindo, Paul worked at Barr Labs and Taro Pharmaceuticals. Paul holds a BA from State University of New York at Binghamton.
Brian McCormick
Brian McCormick is currently the Vice President – Chief Regulatory Counsel at Teva Pharmaceuticals. He also leads Teva’s Global Research and Development Legal organization. During his time at Teva, he also spent over three years as the Head of Global Regulatory Policy. Prior to his joining Teva, Brian served as the Assistant General Counsel – Pharmaceutical […]
Emily King
Emily M. King serves as General Counsel and Vice President of Accord Healthcare, Inc., serving as a strategic partner to business unit leaders internally and with partners, customers and vendors worldwide. Accord Healthcare is a wholly-owned subsidiary of Intas Pharmaceuticals, Limited, a pharmaceutical company with a footprint in 85 countries that focuses on oncology products. As […]
Marc Kikuchi
Marc Kikuchi is the President and Business Head of North America at Glenmark Pharmaceuticals Incorporated. He is responsible for operations, and strategic and growth portfolio of the company in the region. Spanning over three decades, Marc has held multiple and diverse roles of increasing responsibility. Prior to joining Glenmark in 2024, he worked with Dr. Reddy’s […]
Milan Kalawadia
Milan Kalawadia is the Chief Executive Officer, North America at Dr. Reddy’s Laboratories Inc. He is responsible for leading the North America business and serves as a member of the Board of Dr. Reddy’s Laboratories, Inc. Milan has more than 19 years of experience in the pharmaceutical marketplace. He has been with Dr. Reddy’s since 2006. […]
Bob Hoffman (Vice Chair)
Bob Hoffman is AAM Vice Chair and Chief Commercial Officer of US Generics for Lupin Pharmaceuticals, Inc. In this role, he is responsible for executing the strategic direction of the business and all of the Commercial Operations functions. He has been with Lupin since 2005 and has over 31 years of experience in the pharmaceutical industry. […]
Keren Haruvi (Chair)
Keren Haruvi is AAM Board Chair and President of Sandoz North America. In her role at Sandoz, she leads Sandoz’s largest commercial and country organization – the United States – which is responsible for approximately a quarter of the global revenue for Sandoz Inc. She also oversees Sandoz commercial operations in Canada, and is a member […]
